Following the continous increase on the number of people with chronic kidney disease ( CKD) a dialysis unit (renal centre) has been established at David Umahi F ...
H.C. Wainwright reiterated its Buy rating and $7.50 price target for Akebia Therapeutics (NASDAQ:AKBA) stock, which is currently trading near its 52-week high of $2.48 and has shown remarkable ...